BIODESIX, INC. Revenue Breakdown
No Revenue Breakdown for BDSX on this site yet.
- 2025-12-31: Others Not split by product in the filing$88.50M100.00%; Total revenue $88.50M.
- 2024-12-31: Others Not split by product in the filing$71.32M100.00%; Total revenue $71.32M.
- 2023-12-31: Others Not split by product in the filing$49.09M100.00%; Total revenue $49.09M.
- 2022-12-31: Others Not split by product in the filing$38.21M100.00%; Total revenue $38.21M.
Source checked: the stored Revenue Breakdown page for BDSX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $88.50M 100.00% | $88.50M |
| 2024-12-31 | Not split by product in the filing $71.32M 100.00% | $71.32M |
| 2023-12-31 | Not split by product in the filing $49.09M 100.00% | $49.09M |
| 2022-12-31 | Not split by product in the filing $38.21M 100.00% | $38.21M |
| 2021-12-31 | Not split by product in the filing $54.51M 100.00% | $54.51M |
| 2020-12-31 | Not split by product in the filing $45.56M 100.00% | $45.56M |
| 2019-12-31 | Not split by product in the filing $24.55M 100.00% | $24.55M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $26.86M 100.00% | $26.86M |
| 2026-03-31 | Not split by product $25.55M 100.00% | $25.55M |
| 2025-12-31 | Not split by product $28.75M 100.00% | $28.75M |
| 2025-09-30 | Not split by product $21.77M 100.00% | $21.77M |
| 2025-06-30 | Not split by product $20.02M 100.00% | $20.02M |
| 2025-03-31 | Not split by product $17.96M 100.00% | $17.96M |
| 2024-12-31 | Not split by product $20.43M 100.00% | $20.43M |
| 2024-09-30 | Not split by product $18.15M 100.00% | $18.15M |
| 2024-06-30 | Not split by product $17.93M 100.00% | $17.93M |
| 2024-03-31 | Not split by product $14.82M 100.00% | $14.82M |
| 2023-12-31 | Not split by product $14.67M 100.00% | $14.67M |
| 2023-09-30 | Not split by product $13.49M 100.00% | $13.49M |
| 2023-06-30 | Not split by product $11.87M 100.00% | $11.87M |
| 2023-03-31 | Not split by product $9.06M 100.00% | $9.06M |
| 2022-12-31 | Not split by product $9.61M 100.00% | $9.61M |
| 2022-09-30 | Not split by product $11.11M 100.00% | $11.11M |
| 2022-06-30 | Not split by product $10.95M 100.00% | $10.95M |
| 2022-03-31 | Not split by product $6.55M 100.00% | $6.55M |
| 2021-12-31 | Not split by product $7.22M 100.00% | $7.22M |
| 2021-09-30 | Not split by product $6.53M 100.00% | $6.53M |
| 2021-06-30 | Not split by product $11.88M 100.00% | $11.88M |
| 2021-03-31 | Not split by product $28.87M 100.00% | $28.87M |
| 2020-12-31 | Not split by product $27.03M 100.00% | $27.03M |
| 2020-09-30 | Not split by product $9.19M 100.00% | $9.19M |
| 2020-06-30 | Not split by product $4.24M 100.00% | $4.24M |
| 2020-03-31 | Not split by product $5.10M 100.00% | $5.10M |
| 2019-12-31 | Not split by product $8.27M 100.00% | $8.27M |
| 2019-09-30 | Not split by product $3.94M 100.00% | $3.94M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |